Abiopharma

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0000950103-26-013065 <b>Size:</b> 246 KB

New Form 424B2 - WELLS FARGO & COMPANY/MN <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001839882-26-042242 <b>Size:</b> 647 KB

New Form 424B2 - ROYAL BANK OF CANADA <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0000950103-26-013064 <b>Size:</b> 564 KB

(99% Neutral) QUOIN PHARMACEUTICALS, LTD. (QNRX) Provides Update on agents for gross proceeds

CRISPR Therapeutics Presents Phase 1a Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and LDL Lowering at ESC Congress 2026

Form 8.3

New Form 424B2 - ROYAL BANK OF CANADA <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0000950103-26-013063 <b>Size:</b> 234 KB

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025347 <b>Size:</b> 548 KB

General Announcement: Minutes of the 34th Annual General Meeting held on 29 July 2026

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0000950103-26-013062 <b>Size:</b> 425 KB

New Form FWP - BANK OF NOVA SCOTIA <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001839882-26-042240 <b>Size:</b> 78 KB

Director Soloway Donna Anne 🔴 sold 50.0K shares (1 derivative) of NAPCO SECURITY TECHNOLOGIES, INC (NSSC) at $35.98 ($1.8M) Transaction Date: Aug 26, 2026 | Filing ID: 000002

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Changes in Interest of Director / Chief Executive Officer

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0000950103-26-013061 <b>Size:</b> 964 KB

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Changes in Interest of Director